Study to Evaluate Vibegron on Patient Treatment Satisfaction

Recruiting

18 years - 99 years

All

20 participants needed

1 Location

Brief description of study

The purpose of this study is to understand: • If you’re satisfied using GEMTESA ® (Vibegron) • What side effects (if any) you may experience using GEMTESA ® (Vibegron) • How GEMTESA ® (Vibegron) impacts your quality of life, • If you need any additional treatment for Overactive Bladder (OAB) besides GEMTESA® (Vibegron). . Participation in the study is expected to last up to 12 months (1 year) but can be extended to 24 months (2 years). Compensation maximum $200.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Overactive Bladder
Age: 18 years - 99 years
Gender: All

Updated on 04 Aug 2024. Study ID: 851067

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Study to Evaluate Vibegron on Patient Treatment Satisfaction Quality of Life and Healthcare Resource Utilization in Patients with Overactive Bladder

Brief description of study

Eligibility of study

Find a site

Interested in the study